1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
Entegrion Logo

Entegrion Announces Launch of Consumer Sales for Stasilon

RTP-based Entegrion, which is developing blood coagulation and related technologies, is launching commercial sales of its Stasilon wound dressings that are designed to stop blood loss.

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Nov 06, 2008 -
– Conventional cotton gauze has long been the standard for controlling bleeding, but Entegrion’s Stasilon® dressing will soon change how consumers care for wounds. Entegrion has just announced that LC Industries of Durham, N.C., will handle consumer sales of Stasilon® - FR through its secure online ordering system. First responders, medical professionals and military personal are already using Stasilon® - FR to quickly stops blood loss of both major and minor wounds.

While Stasilon® was originally created for the military in consultation with the U.S. Office of Navel Research, it can also be extremely useful at home or on the jobsite for minor abrasions or to stabilize more serious injuries while seeking professional medical help. Uncontrolled bleeding is the second leading cause of death in the United States, after trauma, and more than 6 million bleeding wounds are treated annually by trauma and emergency rooms in the U.S. Unlike absorbent cotton, the combination of glass and bamboo used in the dressing’s fibers trigger the body’s natural mechanisms for hemorrhage control by rapidly constricting and clotting damaged blood vessels. Wounds become stabilized and blood loss is drastically reduced.

Stasilon® - FR is a wound dressing cleared by the FDA for use by individuals in virtually any environment. No training or special instructions are required. You simply open the package, apply the dressing to the wound and maintain firm pressure. These innovative wound dressings are available for purchase in quantities of 10 in a four-inch or two-inch square size. Visit www.entegrion.com to order.

# # #

Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, resuscitation and associated tissue repair. The company is the inventor of Stasilon® – the hemostatic medical textile technology cleared by the FDA – from which multiple hemorrhage control products are being made.

Building upon technologies licensed from the University of North Carolina, Entegrion’s portfolio includes platelet-derived platform technologies that are being developed as topical gels and sprays for tissue repair, infusible hemostatic agents for the control of internal hemorrhage, and novel vehicles for delivery of drugs to targeted tumors and other sites of internal bleeding. Entegrion has also developed proprietary techniques for drying plasma and other blood components to provide for long shelf life with rapid rehydration for emergent and clinical use.

--- end ---

Click to Share

Contact Email:
Source:Lauren Whaley
Phone:919-929-0225
Fax:919-968-8278
Address:104-A North Elliott Road
Zip:27514
City/Town:Chapel Hill
State/Province:North Carolina
Country:United States
Industry:Biotech, Health, Medical
Tags:, , , consumer sales
Last Updated:Nov 06, 2008
Shortcut:http://prlog.org/10137643
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share